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Abstract
Background: In Drosophila embryos, many biochemically and functionally unrelated transcription factors bind
quantitatively to highly overlapping sets of genomic regions, with much of the lowest levels of binding being
incidental, non-functional interactions on DNA. The primary biochemical mechanisms that drive these genome-
wide occupancy patterns have yet to be established.
Results: Here we use data resulting from the DNaseI digestion of isolated embryo nuclei to provide a biophysical
measure of the degree to which proteins can access different regions of the genome. We show that the in vivo
binding patterns of 21 developmental regulators are quantitatively correlated with DNA accessibility in chromatin.
Furthermore, we find that levels of factor occupancy in vivo correlate much more with the degree of chromatin
accessibility than with occupancy predicted from in vitro affinity measurements using purified protein and naked
DNA. Within accessible regions, however, the intrinsic affinity of the factor for DNA does play a role in determining
net occupancy, with even weak affinity recognition sites contributing. Finally, we show that programmed changes
in chromatin accessibility between different developmental stages correlate with quantitative alterations in factor
binding.
Conclusions: Based on these and other results, we propose a general mechanism to explain the widespread,
overlapping DNA binding by animal transcription factors. In this view, transcription factors are expressed at
sufficiently high concentrations in cells such that they can occupy their recognition sequences in highly accessible
chromatin without the aid of physical cooperative interactions with other proteins, leading to highly overlapping,
graded binding of unrelated factors.
Background
In vivo crosslinking studies show that a wide range of
animal transcription factors each bind to many thou-
sands of DNA regions throughout the genome and that
not all of this binding is necessarily functional (for
example, [1-19]). For example, our studies of over 20
transcriptional regulators in the Drosophila blastoderm
embryo show that the few hundred most highly bound
DNA regions include all of these proteins’ known target
cis-regulatory modules (CRMs) and are preferentially
associated with developmental control genes and genes
whose expression is strongly patterned in the blasto-
derm [1-3,14,17,19]. In contrast, the thousands of more
poorly bound regions are preferentially associated with
genes not transcribed in the early embryo and/or house-
keeping genes, and are frequently present in poorly con-
served non-coding DNA or in protein coding sequences.
In addition, there is a surprisingly high overlap in the
genomic regions bound by biochemically and function-
ally unrelated animal transcription factors in vivo
[3,17,20], with the distinct biological specificities of fac-
tors being determined by quantitative differences in
their occupancy on these shared regions [3,17,21,22].
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for these widespread, overlapping patterns of animal
factor binding? Most animal transcriptional regulators
recognize short degenerate DNA sequences that occur
frequently near most genes [23]. Only a subset of these
sites, however, are highly occupied in vivo in a given
cellular or developmental context, and the level of
occupancy at each site correlates only poorly with a
given factor’s intrinsic DNA recognition properties
[3,6,14,24,25]. Thus, as long recognized, one or more
mechanisms must differentially alter the relative occu-
pancy of factors across the genome.
Two such mechanisms have been characterized. The
first is direct heteromeric cooperative interactions
between pairs of factors bound to adjacent sites in the
genome that selectively increase occupancy only to
regions where appropriately spaced sites for both factors
occur [26-30]. The second is competition for DNA
binding with other sequence-specific factors, nucleo-
somes or other chromatin-associated proteins that selec-
tively reduces binding at a subset of sites [31-39]. While
t h e r ei se v i d e n c et h a tb o t hh a v es o m ei n f l u e n c eo n
DNA binding in vivo [12,25,26,30-32,38-45], there has
been no systematic effort to quantify the relative contri-
butions of these positive and negative effects on the
overall pattern of factor binding.
One common set of models invokes a prominent role
for direct cooperative interactions, suggesting that tran-
scription factors cannot significantly occupy their func-
tional target sites without such interactions between
factors [26-30]. These ‘direct cooperativity’ models have
been used to predict that transcription factors will bind
highly selectively in non-overlapping patterns, each fac-
tor binding to relatively few genes [28,29], and that fac-
tors with similar intrinsic DNA recognition properties,
such as the HOX proteins, may be targeted to different
genes through differential interactions with cooperativity
partners [26,30]. These predictions, however, are diffi-
cult to reconcile with the measured patterns of DNA
binding in vivo and, in the case of HOX factors, with
their ultimate regulation of a very large pool of common
genes [2,46].
Instead, to explain the widespread, overlapping pat-
terns of factor binding in animals, we have previously
suggested that transcription factors are expressed at suf-
ficiently high cellular concentrations that they detectably
occupy most high and moderate affinity recognition
sequences that are physically accessible in the context of
chromatin, without the aid of heteromeric cooperative
interactions with other factors [3,14,41,46]. In this ‘wide-
spread binding’ model, nucleosomes and other chroma-
tin proteins would block access to much of the genome
[12,25,31,32,40-45]. At the same time, accessible,
nucleosome-depleted regions, such as active CRMs,
would be bound at high levels by factors exerting an
essential function, but would also be bound at lower
levels by other factors interacting opportunistically with
fortuitously occurring cognate recognition sequences.
Here we seek to quantify the relative contributions of
the direct cooperativity and widespread DNA binding
models in the context of the quantitative genome-wide
in vivo binding patterns of Drosophila developmental
regulators. Genome wide DNaseI digestion data are
used to provide a biophysical measurement of the access
an exogenous protein has to DNA in nuclei. Since the
access a protein has to DNA must affect its level of
occupancy on DNA, the DNaseI data measure the con-
tribution to the final pattern of factor binding due to
competitive inhibition of binding. In contrast, local gen-
ome accessibility is not altered, per se, by direct hetero-
meric cooperative interactions. Thus, by establishing the
quantitative correlation between accessibility and levels
of factor binding, we can both determine accessibility’s
contribution to DNA binding and set an upper limit, by
the extent of non-correlation, for the contribution that
direct heteromeric cooperativity makes.
It is important to note that indirect cooperativity, a
mechanism by which binding of two or more factors
mutually increase each others ability to competitively dis-
place a nucleosome without making direct physical con-
tacts with each other [47-56], is quite distinct from direct
cooperativity. Indirect cooperativity is fully consistent
with the widespread binding model. It assumes that at
least some factors are expressed at sufficiently high con-
centrations that they can bind their sites without direct
interactions with other factors. It also provides a ready
explanation for the high overlap in factor binding
because it naturally leads to increased binding of any fac-
tors whose recognition sites lie within the DNA region
from which a nucleosome has been displaced. Here, how-
ever, we make no attempt to distinguish whether this or
other mechanisms are the chief cause of the differential
accessibility of the genome. By using direct independent
measurements of accessibility and then by considering
the effect this has on each factor separately, we unlink
targeting of individual factors from the challenging ques-
tion of how the hundreds of transcription factors
expressed in each cell, together with the chromatin
remodeling/modification enzymes that they recruit, alter
chromatin structure [34,35,37-40,57,58].
Results
Factor binding is concentrated in highly accessible
chromatin
The accessibility of genomic DNA sequences in the con-
text of chromatin in vivo has classically been studied
using digestion of DNA in isolated nuclei by the non-
specific endonuclease DNaseI [59-61]. Using a high-
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have previously profiled DNA accessibility genome-wide
in native chromatin at high resolution across stages 5, 9,
10, 11 and 14 of Drosophila embryogenesis, spanning
the first 11 hours of development (S Thomas et al., sub-
mitted). Even though data for independent replicas from
collections of embryos at the same stage of development
were highly reproducible (r ≥ 0.91; S Thomas et al., sub-
mitted; Additional files 1 and 2), to derive a conservative
picture of chromatin accessibility, and to minimize the
effect of experimental variability, we reanalyzed these
data to identify genomic regions with increased DNaseI
sensitivity at a 5% false discovery rate (FDR) that were
concordant between pairs of replicas. We identified
between 16,217 and 24,373 such DNaseI accessible
regions per stage, collectively spanning 9 to 13% of the
euchromatic genome (Additional files 1, 2 and 3). Con-
sistent with our original results (S Thomas et al., sub-
mitted), approximately half of the accessible regions
present at a particular stage show little change in acces-
sibility over time, whereas the remaining regions display
marked increases or decreases in DNaseI sensitivity dur-
ing embryogenesis.
We next compared the DNase-seq data for stage 5
embryos to in vivo DNA binding data at the same stage.
At this point in development, the embryo is a single
layer of approximately 6,000 undifferentiated cells,
which are each likely to have similar patterns of chro-
matin structure, providing a relatively simple system for
our analysis [64]. We used DNA binding data for 21
sequence-specific transcription factors, TFIIB, and the
transcriptionally active form of RNA polymerase II that
had been quantified by genome-wide in vivo formalde-
hyde crosslinking (ChIP-chip) [14,17]. Only high-confi-
dence bound regions above the 1% FDR threshold were
examined, giving a conservative picture of the total
amount of factor binding.
An extensive set of controls indicate that our ChIP-chip
data provide an accurate measure of the relative levels of
factor directly contacting the different genomic DNA
regions to which they are crosslinked [3,14,17,41,65]. For
example, in vitro controls show that formaldehyde cross-
linking of purified transcription factors to naked DNA is
proportional to factor occupancy on the DNA; quantita-
tive PCR and bacterial artificial chromosome ‘spike-in’
experiments show that the whole genome amplification
used in our ChIP-chip experiments preserves the relative
differences in enrichment of various genomic regions; and
in vivo UV crosslinking results show that similar data are
obtained when protein-protein crosslinking is absent. In
light of a recent paper showing that sonication of intact
nuclei can lead to the preferential release of short (<350
bp) DNA fragments from accessible genomic regions [66],
we also note that the crosslinked DNA used in our ChIP-
chip experiments is sonicated only after it has been puri-
fied away from non-covalently attached proteins and that
the resulting DNA fragments are mostly longer than
350 bp (mean size approximately 600 bp). As a result, our
crosslinked input DNA samples show no evidence of bias
towards genomic regions that are either highly accessible
to DNaseI digestion or highly bound by factors (Additional
file 4). Further, the quantification of ChIP-chip data
(ChIP-chip scores) used throughout this and our previous
work, with the exception of that in Additional file 4, were
calculated by dividing the array hybridization signal from a
factor immunoprecipitation by the array signal from the
exactly matched, ‘input’ crosslinked DNA sample [14],
which would correct for any DNA extraction bias that had
occurred.
Figure 1 compares DNase-seq and the ChIP-chip data
for the even-skipped (eve) locus at stage 5. This well
characterized target gene contains five CRMs that mole-
cular genetics indicate are each bound and regulated by
combinations of the 21 regulatory factors at this stage of
embryo development [67-69]. These proteins are
expressed in different spatial patterns and either activate
or repress transcription such that, while the eve gene is
only expressed in a subset of cells, each CRM is
expected to be accessible and bound by at least some of
these factors in all cells [67-69]. Consistent with this, all
five CRMs show peaks of DNA binding for many of the
21 factors (Figure 1). Local peaks of DNaseI accessibility
align very well with both the CRMs and peaks of factor
binding, with the DNase-seq peaks varying in intensity
(reflected in the density of mapped DNA sequence tags)
over approximately a ten-fold range (Figure 1). While
this variation in peak intensity is higher than that
expected and may reflect differences in experimental
bias in each assay, analyses presented later in the paper
indicate that, when averaged over multiple regions,
DNase-seq signals do correlate with levels of factor
occupancy. A high overlap between genomic regions
identified by DNase-seq and ChIP-chip is also apparent
across much longer regions of the genome (Figure 2),
wherein the strongest peaks of factor binding almost
uniformly align with major peaks of DNaseI accessibility
in stage 5 chromatin.
To quantify the global correlation between factor
binding and DNaseI accessibility, we first determined
the proportion of ChIP-chip peak regions that over-
lapped 5% FDR accessible regions at stage 5 (see Materi-
als and methods; Additional file 5). Combining data
from all 21 factors, RNA polymerase II and TFIIB, we
observed a strikingly high overlap (mean 87%, range 71
to 99%, probability of observing a higher overlap ran-
domly <1 × 10
-16). We also determined the proportion
of accessible regions that coincided with genomic
regions bound by one or more of the 21 sequence-
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regions encompass only approximately 12% of the
euchromatic genome, 61% of these regions coincide
with binding for at least one of the 21 factors (probabil-
ity of a greater overlap occurring by chance <1 × 10
-16),
or 65% if RNA polymerase and TFIIB binding are
included. By contrast, only 7% of the genome that is at
least 500 bp away from accessible chromatin is covered
by 1% FDR ChIP-chip regions (probability of getting less
overlap at random <1 × 10
-16). Moreover, the most
accessible regions displayed even higher levels of overlap
with regulatory factor binding sites. Of the 5,000 most
accessible regions, 95% are occupied by at least one of
the 21 factors above the 1% FDR threshold, with nearly
monotonically decreasing overlap with decreasing chro-
matin accessibility (Additional file 6).
Quantitative relationship between genome accessibility
and factor occupancy
Because our previous studies establish that it is the level
of regulatory factor occupancy on a given genomic
region that is an important determinant of function,
rather than if a region is detectably bound or not
[2,3,14,17], we next performed a quantitative compari-
son of factor binding and accessibility. We calculated
median DNaseI scores for cohorts of 200 ChIP-chip
peaks, grouped and ranked according to their ChIP-chip
scores in stage 5 embryos (see Materials and methods).
This analysis revealed that, for each factor, the regions
that are most highly bound are significantly more acces-
sible than regions bound at lower levels (Figure 3; Addi-
tional file 7). This result is most compelling for those
f a c t o r sw i t ht h em o s tr e g i o n si d e n t i f i e da b o v et h e1 %
FDR ChIP-chip threshold, since in these cases false posi-
tives should not contribute significantly to the median
DNaseI score above this threshold; notably, however, all
factors show this trend.
We confirmed that the aforementioned relationship is
quantitative - that is, that the lower median accessibility
of cohorts of poorly bound regions largely derives from
reduced accessibility of each region rather than a
reduced number of accessible regions versus highly
bound cohorts. This is illustrated clearly by the fact that
the proportion of ChIP-chip peaks that overlap accessi-
ble regions reduces more gradually down the rank list
than do DNaseI scores (Figure 3; Additional file 7). For
example, for the sequence-specific factor Dichaete (D) at
ChIP-chip rank 2,000 when accessibility is reduced by
two-fold, the percent overlap drops only marginally.
The plots in Figure 3 also show that regions bound
highly by factors in stage 5 are much less accessible at
stage 14 than at stage 5, even though we have previously
shown that both stages contain a similar number and
length of accessible regions, and the median accessibility
of accessible regions at stage 14 is fully 78% of that at
stage 5 (S Thomas et al., submitted; Additional file 2).
Thus, most genomic regions bound at high levels by
regulatory factors at stage 5 have their accessibility spe-
cifically reduced at later stages of development, consis-
tent with the known inactivation of many early active
CRMs.
Genome accessibility and intrinsic factor specificity
determine occupancy in vivo
The above analyses establish a close quantitative rela-
tionship between genome accessibility and local levels of
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Figure 1 DNaseI accessibility and in vivo DNA binding by
transcription factors across the eve locus. DNA binding in stage
5 embryos is shown as ChIP-chip scores (blue) for 675-bp windows
that fall above a 1% FDR threshold for 21 sequence-specific
transcription factors, TFIIB and the transcriptionally active form of
RNA polymerase II (POLII). The sequence-specific factors are
grouped into three major regulatory classes that regulate patterning
along the Dorsal-Ventral axis of the embryo (D-V), initiate patterning
along the Anterior-Posterior axis (Early A-P), or establish later pair
rule patterns along the Anterior-Posterior axis (Pair rule A-P). DNaseI
accessibility at stage 5 is shown for 75-bp windows of sequence tag
density (red) along with the locations of accessible regions above
the 5% FDR threshold (black bars). At the bottom, the locations of
major RNA transcripts are shown (grey) as well as the
autoregulatory CRM (Auto) and the four stripe initiation CRMs (S3/7,
S2, S4/6 and S1/5) (green). Nucleotide coordinates in the genome
are given in base pairs.
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the pattern of binding is determined principally by gen-
ome accessibility per se, or whether it is the binding of
regulatory factors that potentiates chromatin accessibil-
ity. As described in the Introduction, ultimately, it is the
combined action of all of the hundreds of sequence-spe-
cific factors in a given cell, together with the chromatin
remodeling proteins that they recruit, that is likely to
determine the pattern of chromatin accessibility
[34,35,37-40,47-58]. We therefore focused our attention
on the more immediately tractable question of whether,
for each single factor in turn, observed chromatin acces-
sibility (however originated mechanistically) has a major
effect on determining that factor’s binding pattern.
To address this question, we first compared the influ-
ence on levels of in vivo factor occupancy of both genome
accessibility and the intrinsic specificity of factors for
naked DNA as determined in vitro using purified protein.
All of the 16 factors for which there are sufficiently accu-
rate position weight matrices (PWMs) of intrinsic specifi-
city [17,70] (Berkeley Drosophila Transcription Network
Project (BDTNP), unpublished data) were examined. We
segmented the genome into accessible and closed chroma-
tin compartments based on the 5% FDR accessible regions.
We then scanned each compartment and annotated all
significant matches to each of the 16 factor PWMs, and
then classified these into several affinity cohorts. To pro-
vide a negative control, we also separately identified for
each factor equivalent cohorts of matches to sets of
PWMs for which the order of nucleotide positions had
been randomly permutated. At the location of each match
to the genuine or scrambled PWMs, the median ChIP-
chip score of the region ±250 bp around the match was
calculated. The highest affinity cohorts typically contained
1,000 recognition site occurrences in accessible chromatin
and 12,000 in closed regions, whereas the lowest affinity
chr3L: 15,550,000 15,600,000 15,650,000
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Figure 2 DNaseI accessibility and in vivo DNA binding by transcription factors across a 200-kb genomic region. The figure is labeled
using the same conventions in Figure 1 except that the RNA transcript locations are shown in light blue at the bottom.
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(Table 1).
This analysis revealed that, among genomic regions
that contain genuine factor recognition sequences of
similar affinity, those in the accessible chromatin (dark
red lines in Figure 4 and Additional file 8) are clearly
bound at significantly higher levels in vivo than those
in inaccessible chromatin regions (dark blue lines in
Figure 4 and Additional file 8). The fact that the same
pattern is evident for 16 factors with widely varying
DNA binding specificities (Additional file 8) strongly
suggests that the observed correlation is not the result
of any sequence bias in regions detected by the
DNase-seq assay, but instead reflects genuinely differ-
ent properties of accessible and closed chromatin
regions. Additionally, the fact that such large effects
are seen when averaged over thousands to millions of
genomic regions strongly suggests that accessibility has
am a j o ri n f l u e n c eo nin vivo occupancy genome-wide.
Further, in 13 out of 16 cases (excepting KNI, PRD, and
FTZ), genomic regions with higher intrinsic affinity
recognition sequences have higher ChIP-chip scores.
Even moderate affinity sites, though, appear to mediate
DNA binding in vivo, albeit at a lower level, as these are
occupied at higher levels than matches to scrambled
PWMs of equivalent affinity for all 16 factors (compare
the dark red and light red lines in Figure 4 and Addi-
tional file 8). Thus, both the intrinsic affinity of a factor
for a given DNA sequence and the accessibility of the
site contribute to the pattern of genome binding in vivo.
We next focused exclusively on accessible genomic
regions, and asked which component - measured factor
occupancy in vivo or the intrinsic affinity of factors for
DNA - was more closely correlated with chromatin
accessibility. To address this, we grouped accessible
regions into ranked cohorts of 200 based on the peak
density of mapped DNaseI cleavages within each region,
and plotted the median ChIP-chip scores and the num-
ber of recognition sequences (at the P < 0.003 matching
level) in each cohort (Figure 5).
For all 16 factors, we found that observed levels of in
vivo occupancy decline sharply in parallel with accessibil-
ity, most strikingly across the few thousand most accessi-
ble regions, and more gradually after that over the
remaining regions. The fact that a wide array of regulatory
factors with markedly different intrinsic DNA binding and
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Figure 3 Levels of factor occupancy and genome accessibility correlate. The median DNase-seq tag density in non-overlapping cohorts of
200 1-kb ChIP-chip peaks is shown down the ChIP-chip rank list (continuous lines). The ChIP-chip data are from stage 5 embryos and the
DNaseI accessibility data are from stages 5 (green) and 14 (purple). The 95% confidence limit for median DNaseI accessibility of each cohort is
indicated. Shown also is the percent of ChIP-chip peaks that are overlapped by 5% FDR accessible regions in stage 5 embryos (dashed green
line). The regions most highly bound by transcription factors are to the left along the x-axis and results are plotted as far as the 25% FDR cutoff.
The location of the ChIP-chip 1% FDR threshold is indicated by the vertical black dotted line. Results for the regulatory transcription factors (a)
Dichaete (D) and (b) Twist (TWI) are shown. Additional file 7 shows plots for all 21 regulators.
Table 1 Frequency of DNA affinity cohort recognition sequences in accessible and closed genome regions
Affinity
cohort
P-values included Mean number of PWM matches for factors in 5%
FDR accessible regions
Mean number of PWM matches for factors in
closed genomic regions
-5 P <1e-4.5 1,145 12,344
-4 1e-3.5 > P > 1e-4.5 9,938 96,853
-3 1e-2.5 > P > 1e-3.5 94,126 825,406
-2 1e-1.5 > P > 1e-2.5 811,773 6,596,274
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Figure 4 Factor recognition sites in DNaseI accessible regions are more highly bound in vivo than sites in closed chromatin. Separately
for each transcription factor, all significant recognition sequences in the euchromatic genome for four affinity cohorts were identified using
PWMs derived from in vitro DNA binding data (Table 1) [17,70]. In addition, matches to ten PWMs derived by random permutation of nucleotide
position order were derived for each factor. Sites in each affinity cohort for both the genuine and scrambled PWMs present were each classified
as either accessible or inaccessible, using the 5% FDR DNaseI accessible regions to define accessible regions (Table 1). The median ChIP-chip
scores (y-axis) for the 500-bp regions ±250 bp around recognition sites in each affinity cohort were plotted separately for accessible (red lines)
and inaccessible (blue lines) genomic regions. Dark red and blue lines show results for the genuine factor PWMs, light red and blue lines the
median result for the scrambled PWMs. The highest affinity cohort is to the left (x-axis). Web logo representations of the PWM representing the
highest and lowest affinity cohorts of genuine recognition sites are shown at the bottom. The 95% confidence limits for the median ChIP-chip
scores are indicated. Plots for (a) CAD, (b) GT, (c) KNI, and (d) HRY are shown. Additional file 8 provides similar plots for all 16 factors for which
sufficiently accurate PWMs are available.
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their levels of occupancy across a diverse array of genomic
elements alone implies that some common principle is
directing the pattern of binding. The strong correlation of
binding with accessibility suggests that the degree of
access that factors have to DNA is the common force driv-
ing the otherwise surprisingly similar behavior of factors.
This view is further supported by the fact that the intrinsic
DNA recognition properties of factors correlate much
more poorly with accessibility than does in vivo occu-
pancy, suggesting that access to DNA plays a larger role in
determining occupancy in vivo than does intrinsic specifi-
city (r = 0.03 to 0.12 versus r = 0.32 to 0.6; Figure 5). For
each factor, the density of recognition sequences drops
more gradually down the rank list of accessible genomic
regions than do either levels of in vivo occupancy or
DNase-seq scores (Figure 5). Indeed, for many factors the
most accessible cohorts have fewer recognition sites than
regions 2,000 to 6,000 down the rank list. There is higher
correlation between site density and accessibility for a few
factors (especially HRY, RUNT and SNA), which could
suggest that these proteins play a pioneering role in deter-
mining the pattern of genome accessibility, similar to tran-
scription factors such as the glucocorticoid receptor
[44,49]. This correlation, however, is still low (<0.13), sug-
gesting that accessibility is affecting their binding more
than any of them are affecting it.
Developmental alterations in genome accessibility direct
changes in factor binding
The above analyses strongly support the ‘widespread bind-
ing’ model in that they suggest that the accessibility of
DNA in chromatin plays a major role in determining the
pattern of in vivo DNA binding for each transcription fac-
tor. These analyses, however, are largely of events at a sin-
gle stage (stage 5). As described above, we have shown
that many regions bound by developmental regulators at
this stage become inaccessible in later embryogenesis
(Figure 3; Additional file 7) and regions bound by factors
in later stages are inaccessible at stage 5 (S Thomas et al.,
submitted). Such perturbations of the chromatin landscape
during development provide a unique and rigorous oppor-
tunity to assess the extent to which the patterns of regula-
tory factor DNA binding are caused by accessibility, as
follows. Since changes in factor binding between stages
are necessarily measured on the same genomic regions,
any alteration in occupancy cannot be due to differences
in DNA sequence, but must instead derive from temporal
changes in the influence of other proteins on binding,
including occlusion by nucleosomes. While direct positive
cooperative interactions with other sequence-specific fac-
tors could, in principle, be responsible for most of the
temporal alterations in DNA binding, this cannot be the
case if these alterations in DNA binding are highly corre-
lated with changed DNA accessibility. In such cases, since
changed accessibility must affect factor DNA binding and
do so in proportion to the degree of that change, any addi-
tional influences on DNA binding due to heteromeric
cooperative interactions and other effects must be limited,
at most, to the residual extent that altered DNA binding
and accessibility do not correlate. In other words, a tem-
poral analysis sets an upper bound on all other influences
on factor binding, beyond chromatin accessibility and the
intrinsic affinity of factors for DNA.
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Figure 5 Accessibility better explains in vivo occupancy than does intrinsic affinity. We identified and grouped 150-bp local peaks of
accessibility within DNaseI accessible regions into non-overlapping cohorts of 200 peaks down the DNase-seq rank list. (a) The median ChIP-
chip score in each cohort for each factor. (b) The sum of occurrences of recognition sequences that match the factor’s PWM (P < 0.003) in each
cohort for each factor. The bottom row in each panel shows the relative DNase-seq scores for each cohort. Data for each factor were normalized
by scaling the median value for each row and plotted as a heat map. The correlation coefficients of the data for each factor with the DNase-seq
scores are shown on the right. The correlations are calculated using data for each accessible region, not the cohort average values.
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developmentally programmed changes in chromatin
accessibility, we analyzed in vivo occupancy data for two
regulatory factors: hunchback (HB) at stage 9, at which
time this factor is expressed in neuroblasts [71], and
Medea (MED) at stages 10 and 14, which is expressed
in all cells during embryogenesis, but is activated only
in changing subsets of cells in response to transforming
growth factor-b signaling [72-74].
Both MED and HB exhibit temporal changes in occu-
pancy, which visualization at individual gene loci suggests
accompany programmed changes in chromatin accessi-
bility (Figure 6; Additional file 9). A larger scale quantifi-
cation of the change in factor binding shows that,
between stage 5 and stages 9, 10 or 14, the correlation
between binding levels for a given factor genome-wide
range between r = 0.33 and r = 0.83, whereas the correla-
tion between biological replicates at the same stage is r =
0.93 (Additional file 10). At most regions, therefore, the
changes in levels of binding between stages for a protein
are moderate, but are clearly distinguished from experi-
mental variability between biological replicates.
To quantify the relationship between these temporal
changes in factor occupancy and alterations in genome
accessibility, we focused on the 400 most highly bound
genomic regions at each stage. We then calculated for
each highly bound region the ratio of ChIP-chip scores
between pairs of stages for a factor and separately the
ratio of the density of DNaseI cleavage between the
same stages and then took the correlation between these
two ratios (Figure 7). An advantage of this analysis strat-
egy is that taking ratios within each data class first will
greatly reduce any systematic bias introduced by either
experimental protocol. Thus, analyzing the ratios will
allow a more accurate comparison between two data
types. Representative results for HB are shown in Figure
7, which reveals a clear correlation between temporal
changes in binding and temporal changes in accessibil-
ity. Significant correlations (r = 0.49 to 0.8, P-values all
<0.001) were likewise observed for all six pairwise com-
parisons between factors and stages (Figure 7; Addi-
tional file 11). Although strong, these correlations
should be regarded as minimum estimates of the degree
to which accessibility influences binding as remaining
experimental biases in the data not removed by taking
ratios will prevent a complete correlation.
Discussion
We have shown that the phenomenon of widespread,
overlapping patterns of DNA binding by different
Stage 5
Stage 9
chr3R 4515000 4520000 4525000 4530000
hb
CG8112
- -
chr2L 20755000 20760000 20765000 20770000
cad
      HB 
ChIP-chip
DNase-seq
DNase-seq
      HB 
ChIP-chip
Figure 6 Levels of HB factor occupancy and DNaseI accessibility change between developmental stages. The level of hunchback (HB)
binding and DNaseI accessibility to the Caudal (cad; left) and hb; right) genes are shown at stages 5 and 9. The figure is labeled using the same
conventions in Figure 1 except that the locations of the regions above the ChIP-chip 1% FDR threshold are indicated by black horizontal lines
beneath the continuous traces of ChIP-chip scores. Additional file 9 shows similar results for Medea (MED).
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embryos is tightly linked in a quantitative manner to
DNA accessibility in chromatin. First, averaged across
the entire euchromatic genome, the level of DNA bind-
ing in vivo at recognition sequences with similar intrin-
sic affinity for a given factor is much higher in
accessible versus inaccessible chromatin for all 16 fac-
tors for which all corresponding data are available
(Figure 4). Within highly accessible regions, the thou-
sands of higher affinity recognition sequences for a sin-
gle factor are generally the most highly occupied in vivo,
but even the hundreds of thousands of moderate affinity
sites are generally bound at higher levels than similar
sites in less accessible regions. Second, the degree of
chromatin accessibility is much more highly correlated
with in vivo occupancy than with occupancy predicted
from in vitro affinity measurements using purified pro-
tein and naked DNA (Figure 5). Third, there is a high
quantitative correlation between programmed changes
in accessibility during embryogenesis and changes in the
level of factor DNA binding (Figure 7). Since the acces-
sibility experienced by transcription factors must
approximate that experienced by DNaseI, the high cor-
relation between the experimentally measured altera-
tions in factor DNA binding and DNaseI digestion
suggests that altered chromatin accessibility is the domi-
nant determinant of the change in binding, as opposed
to other potential influences such as direct heteromeric
cooperative interactions.
All of these results support a previously proposed
‘widespread binding’ model, which was initially based on
comparisons between in vivo UV crosslinking data for
different classes of homeoproteins and in vitro DNA
binding, genetic, restriction enzyme accessibility, and
target gene expression data [2,3,14,41,46]. In this model,
regulatory factors are expressed at sufficiently high con-
centrations in cells that they can detectably occupy their
recognition sequences in highly accessible chromatin
without the aid of physical cooperative interactions with
other proteins. Given the broad DNA recognition prop-
erties of animal transcription factors [23], this would
inevitably lead to highly overlapping, graded binding of
unrelated factors, with the lowest levels of binding being
non-functional [2,3,14,41,46].
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Figure 7 Temporal changes in levels of HB occupancy correlate with changes in DNaseI accessibility. We identified the 1-kb regions
±500 bp of the peak nucleotide of binding for each of the 400 regions most highly bound by HB at (a) stage 5 and (b) stage 9. (a) Scatter plot
of the ratio of ChIP-chip scores at stage 5 over those at stage 9 (x-axis) versus the ratio of DNase-seq scores at stage 5 over those at stage 9 (y-
axis). (b) Scatter plot of the ratio of ChIP-chip scores at stage 9 over those at stage 5 (x-axis) versus the ratio of DNase-seq scores at stage 9 over
those at stage 5 (y-axis). The Pearson correlation coefficients (r) for each comparison are shown in the top right of each panel. See Additional file
11 for similar plots for MED.
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studies presented here lends further credence to this
model [75]. Using a generalized hidden Markov model,
quite accurate quantitative predictions of the patterns of
ChIP-seq in vivo DNA binding for five of the early Dro-
sophila regulators can be made using only in vitro DNA
binding and DNaseI accessibility data as input. No
potential heteromeric interactions could be found in the
model that would improve the prediction of DNA bind-
ing by these proteins, which are known to function in
concert on a common pool of CRMs. Analysis of chro-
matin accessibility before and after induction of DNA
binding of glucocorticoid receptor (GR) in different cell
types also supports the widespread binding model. Not
withstanding the fact that up to 12 to 15% of the
regions bound by this pioneering transcription factor
are inaccessible prior to induction, the remaining GR
recognition sites in the genome that become bound are
accessible prior to induction, with the different locations
of GR binding between cell types largely correlating
with the altered locations of accessible DNA [76].
The widespread binding model incorporates long-
standing predictions that, given the relatively high con-
centrations of transcription factors and DNA in cells,
the majority of factor molecules not bound at high
levels to functional targets should be bound instead at
lower densities to any accessible parts of the genome
[77,78]. These thermodynamic arguments are supported
by various lines of evidence suggesting that the concen-
tration of free, unbound factor molecules in nuclei is
indeed much lower than suggested by the number of
molecules present [79-82]. Such predictions were origin-
ally made for the Lac repressor in Escherichia coli and
assumed that genome-wide, low occupancy binding
would result from the sequence-independent, electro-
static affinity of transcription factors for DNA (KD
approximately 10
-6 M). Given the broad sequence-speci-
fic recognition properties of most animal transcription
factors, however, it is likely that most accessible geno-
mic regions will contain moderate or high affinity (KD <
10
-8 M) recognition sites for many of these proteins
[23,83]. The factors whose in vivo binding we have
examined are typically expressed at tens of thousands of
molecules per cell [1,84] (BDTNP, unpublished data).
Thus, thermodynamically, most of these molecules are
likely to significantly occupy accessible moderate or
high affinity recognition sequences, rather than being
bound via an electrostatic, sequence-independent inter-
action. Indeed, even genomic regions bound at low
levels in vivo are enriched for specific recognition
sequences of a range of affinities ([3,14] and this paper).
DNA recognition sites for factors that would interfere
with the proper regulation of a nearby gene will be
actively selected against [85]. Low level binding at
fortuitously occurring sites that does not lead to biologi-
cally significant transcriptional effects, in contrast,
would not be subject to negative selection, and is con-
sistent with the high amount of apparently incidental
binding of factors detected in vivo [1-3,14,17].
Our analysis does not rule out an important role for
direct heteromeric cooperative interactions between
transcription factors quantitatively modifying binding of
these proteins at a subset of recognition sequences. Our
results, however, set limits on the extent to which direct
positive heteromeric cooperative interactions are likely
to determine the overall distribution of factor binding in
cells. Because accessibility must affect binding, the high
quantitative correlation we have measured between
accessibility and in vivo binding leaves only a modest
role for direct cooperative interactions to further modify
binding.
A much larger role for direct heteromeric interactions
in targeting transcription factor binding has been
invoked where it is assumed that the concentrations at
which factors are expressed in cells are too low to allow
significant occupation of functional target sites without
such interactions [26-30]. This ‘direct cooperativity
model’ is associated with the idea that factors each bind
and regulate a limited number of largely different genes,
even in the same cell type (for example, [29]), and that
even factors with similar intrinsic DNA recognition
properties are targeted to different genes (for example,
[26,30]). Based on the evidence presented here and the
growing recognition that transcription factors bind a
wide array of genomic regions in many animals and cell
types [1-19], the direct cooperativity model may apply
to a relatively limited set of factors and circumstances.
The occurrence of statistically significant local clusters
of recognition sites for multiple transcription factors in
a subset of CRMs modules (for example, [86-92]) could
be taken as evidence for the direct cooperativity model.
Such preferential clustering, however, could also result
because of post-DNA-binding synergistic cooperativity
between factors that does not significantly influence
their targeting to DNA but instead influences members
of the general transcriptional machinery [46,86,93].
Thus, the arrangement of recognition sites in the gen-
ome, while highly informative in detecting putative reg-
ulatory elements, cannot itself distinguish between
different factor targeting mechanisms.
In addition to the long-standing evidence that nucleo-
somes inhibit the binding of transcription factors at some
DNA regions vivo (reviewed by [32,40]), genome-wide
studies have increasingly shown an association between
regions bound by factors in vivo and features of chroma-
tin structure, such as histone modifications, nucleosome
content or accessibility [12,25,42-45,94-101]. These stu-
dies, however, have not shown that functionally distinct
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binding at common regions; nor observed a high quanti-
tative correlation between DNA accessibility and factor
binding; nor considered the classic thermodynamic pre-
dictions of Lin and Riggs [77] and Peter von Hippel [78];
nor sought to distinguish between the ‘widespread bind-
ing’ and the ‘direct cooperativity’ models for transcription
factor targeting. Most of these studies have generally
looked at the association qualitatively. In addition, the
studies in yeast have not measured accessibility directly,
but have attempted to infer it from ChIP-chip studies of
nucleosome occupancy or nucleosome position sequence
data [42], which will likely lead to some inaccuracy as
genome accessibility is the product of all proteins bound
to DNA and also high order chromatin structures. Our
results thus highlight the importance of both measuring
and considering the quantitative nature of factor binding
and genome accessibility and of attempting to distinguish
between alternative targeting models.
Finally, while our analysis does not address how the
distribution of accessible regions in the genome is itself
established, it is consistent with the indirect cooperativ-
ity model proposed by others in which different tran-
scription factors mutually aid each other’s binding to
DNA by displacing a nucleosome without physically
interacting with each other [47-56]. Indirect cooperativ-
ity, we suggest, implies that factors are expressed at a
sufficiently high concentration in cells that they can
occupy their recognition sites without the aid of direct
protein-protein interactions with other proteins. It also
predicts a high overlap in the genomic regions bound by
transcription factors once the broad intrinsic DNA
recognition properties of these proteins are taken into
account. Most factors would be expected to contribute
only a small part to determining the overall pattern of
chromatin accessibility in this model, whereas chromatin
accessibility would be expected to play a large role in
determining the pattern of binding of each factor, when
each is considered individually. The emerging picture is
of a dynamic interplay between nucleosomes and
sequence-specific DNA binding proteins (along with the
remodeling/modification enzymes that they recruit) that
mutually determine each other’s binding patterns
[34,35,37-40,57,58].
Conclusions
Using the Drosophila embryo as a model system, we have
provided a uniquely detailed, quantitative comparison
between DNA accessibility and regulatory transcription
factor occupancy in vivo. These analyses support a long-
standing ‘widespread binding’ model [14,41,46,77-79,102],
which suggests that animal regulatory factors are generally
expressed at sufficiently high concentrations in cells that
they can detectably occupy their recognition sequences in
highly accessible chromatin without the aid of physical
cooperative interactions with other proteins. Given the
broad DNA recognition properties of animal transcription
factors [23], this should inevitably lead to highly overlap-
ping, graded binding of unrelated factors, with the lowest
levels of binding being non-functional, consistent with
extensive in vivo DNA binding and regulatory data in Dro-
sophila [1-3,14,17,19,46]. This simple thermodynamic
model predicts that similar widespread, overlapping DNA
binding by many different regulatory transcription factors
will be found in all animal cells.
Materials and methods
ChIP-chip of HB and MED in late stage embryos
Embryos were collected in population cages for 1 hour,
and then allowed to develop to the required stage before
being harvested and fixed with formaldehyde [14,65].
Chromatin was purified and ChIP-chip experiments were
performed using affinity purified antibodies against HB
and MED as described previously [14,17]. The data were
processed as before to determine 1% FDR and 25% FDR
bound regions and peaks using the symmetric null test
[14] (Figure 2). All raw microarray data (CEL files) have
been deposited at ArrayExpress [ArrayExpress: E-TABM-
1021], and details of the locations of the 1% and 25%
FDR bound regions are provided as Additional file 12. In
addition, these and more processed forms of the data are
available from the BDTNP’s public web site [103].
Determining the intersection of 5% FDR accessible
regions and peaks
The raw DNase-seq DNA sequence tag data are from
Thomas et al.( ’Dynamic reprogramming of chromatin
accessibility during Drosophila embryo development’,
submitted), which used methods described in [41,62,104]
to generate the data. For convenience, the NCBI
Sequence Read Archive accession numbers for these data
are also provided here: [NCBI SRA: STUDY SRP002474,
NCBI SRA EXPERIMENTS SRX020691 to SRX020700]
for stage 5 rep 1 to stage 14 rep 2, respectively). As
described (S Thomas et al., submitted), DNaseI accessible
regions were defined using a scan statistic that identified
regions with DNaseI cleavage densities that were signifi-
cantly above the local 50 kb background. Regions at 5%
FDR were identified (Additional files 2 and 3). Peaks in
accessibility were identified from local maxima in tag
density within 75 bp of a given 20-bp sliding window
across each accessible region (Additional files 2 and 3).
The conservatively defined set of accessible regions and
peaks in accessibility that were found in both replicates
at each stage were used for subsequent analysis (for
example, Additional files 5, 6 and 7).
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The locations of 1% FDR ChIP-chip peaks for 21 factors
at stage 5 were obtained from previously published data
[14,17,103] [Array Express; E-TABM-736]. The percen-
tage of ChIP-chip peaks overlapped by accessible chro-
matin for each factor at stage 5 (Additional file 5) was
calculated by adding the number of instances either
where the 1-kb ChIP-chip peak was overlapped by an
accessible region by at least 200 bp or where a ChIP-
chip peak entirely encompassed a 5% FDR DNaseI
accessible region, and dividing by the total number of
1% FDR ChIP-chip peaks. The significance of this cov-
erage was assessed using two separate methods, a sim-
ple hypergeometric model and the Genome Structure
Correction (GSC) statistic [105]. The hypergeometric
model assessed the likelihood of set A to include ‘q’
base pairs of overlap with set ‘B’,a s s u m i n gnd r a w s
without replacement from the genome where n is the
base-pair coverage of set A. GSC is a more complex
bootstrapping method specifically designed to calculate
probabilities of overlap for sets of genomics features.
For both tests it was impossible to determine with any
further accuracy the probabilities of overlaps for each
factor with greater significance than the de minimus
probability of 1 × 10
-16.
To determine what fraction of the accessible regions
was covered by one or more factors (Additional file 5),
all of the single-nucleotide locations of 1% FDR ChIP-
chip peaks [14,17] for all factors were merged and
padded on either end by 500 bp to account for impreci-
sion in the location of each peak. Peaks in DNaseI
accessibility in stage 5 embryos were ranked from lar-
gest to smallest and divided into cohorts of 1,000 peaks.
If any of the merged ChIP regions fell within 75 bp of a
peak in accessibility, then that DNaseI peak was said to
be ‘covered’ by a ChIP factor. The fraction of peaks that
were bound by any of the factors was calculated as the
number of ‘covered’ peaks divided by the number of
peaks per cohort.
The 25% FDR ChIP-chip peaks for each factor were
ranked from largest to smallest and divided into cohorts
of 200 peaks (Figure 3; Additional file 7). The maximum
DNaseI density for stage 5 and 14 embryos within 500
bp of each ChIP-chip peak was recorded as was whether
or not that peak overlapped a stage 5 DNaseI accessible
region. The number of ChIP-chip peaks in each cohort
that overlapped a stage 5 accessible region divided by
the number of peaks in each cohort was calculated to
determine the percent of ChIP-chip peaks in each
cohort that were in accessible regions. The median and
95% confidence intervals of maximum DNaseI densities
for the ChIP-chip peak cohorts were calculated with R’s
box plot function [106].
Measuring the effect of accessibility and intrinsic factor
specificity on in vivo occupancy
PWMs for 16 transcription factors have previously been
c o l l a t e d[ 1 7 ]f r o mv a r i o u sin vitro SELEX and DNaseI foot-
printing experiments that used purified transcription factor
protein and naked DNA [70] (BDTNP, unpublished data).
For convenience these are provided in Additional file 13.
T h e s eP W M sw e r eu s e dt oi d e n t i f ya l lD N As e q u e n c e s
that match them genome-wide at P-values <0.04 using
Fimo [107]. For each factor, these recognition site occur-
rences were then divided into two groups depending on
whether the matches were located within 5% FDR DNaseI
accessible regions or whether they were in inaccessible
chromatin. The recognition sites were then further broken
down into cohorts in R based on P- v a l u e sa sf o l l o w s :
Cohort ID = Round

log10(P − value)

For each cohort, the maximum ChIP-chip signal from
the relevant factor within 250 bp of each sequence match
was determined using input DNA normalized ChIP-chip
scores calculated as Array hybridization signal for factor
immunoprecipitation/Array hybridization signal for input
crosslinked DNA (see Figure 2 in [14]) except that natural
numbers, not log2, were used here. The 95% confidence
interval about the median of these scores was calculated
using R’s box plot function (Figure 4; Additional file 8).
In addition, ten permutations of each original PWM
were generated by shuffling the order of positions in the
weight matrices for each permutation. If any permuta-
tion that matched any other of the randomly generated
permutations for that factor or the normal PWM of one
of the other 15 factors (P < 0.05 defined using Tomtom
[108]) it was discarded and a new permutation was gen-
erated. The set of sequence matches to these scrambled
PWMs were then identified throughout the genome,
separated into those in open or closed chromatin and
binned into groups based on affinity in the same man-
ner as for the genuine motifs. The maximum ChIP-chip
scores within 250 bp of each scrambled recognition site
occurrence was determined and the median of this peak
s c o r ew a sd e t e r m i n e do v e rt h ee n t i r es e to ft e n
scrambled PWMs for each factor and the 95% confi-
dence limits calculated as for the matches to the genu-
ine PWMs (Figure 4; Additional file 8).
To correlate accessibility with ChIP-chip scores (Figure
5a), peaks in accessibility at stage 5 were annotated with
maximum input DNA normalized ChIP-chip scores within
75 bp of each peak for the 16 factors with well-character-
ized in vitro binding specificities (Figure 4; Additional file
8). The peaks were ranked by accessibility and the correla-
tion between level of accessibility and ChIP-chip score was
calculated using R’s Pearson correlation function. The
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200 similarly accessible peaks and the median peak in
ChIP-chip signal for each cohort was determined and
plotted using R’s heat map function scaling rows to
account for inherent differences in ChIP-chip signal
between factors. A similar process was used to correlate
accessibility with the presence of recognition sites for each
of the 16 factors (Figure 5b). The same PWMs for the fac-
tors derived from in vitro DNA binding data, described
above, were employed to identify all sequence matches to
these matrices within 75 bp of peaks of accessibility with P
< 0.003 using Fimo [107] (that is, matches that fell into at
least the -3 cohort from Figure 4). The correlation
between the level of accessibility and the number of PWM
matches was calculated using R’s Pearson correlation func-
tion. For each factor, the peaks in accessibility were ranked
and divided into cohorts of 200 and the sum of all recog-
nition sites was added over each cohort and plotted in R
using the heat map function, while scaling rows to one
another in order to account for differences in information
content between PWMs.
Correlating temporal changes in factor occupancy and
DNA accessibility
Scatter plots and Pearson correlations were generated
using R (Figure 7; Additional files 10 and 11). Peaks in
ChIP-chip data for HB2 antibody above the 25% FDR
threshold were annotated by the maximum ChIP-chip
s i g n a lf o rH B1a n dH B2w i t h i n5 0 0b po fe a c hp e a k
[17], and these two replicate input DNA normalized
ChIP-chip scores were plotted against each other and a
correlation coefficient calculated (Additional file 10).
This same process was used to assess the correlation
between maximum HB 2 ChIP-chip signal from stage 5
embryos compared to HB 2 ChIP-chip signal from stage
9e m b r y o s ,a sw e l la st oc o m p a r eM E DC h I P - c h i ps i g -
nals from stage 5, 10 and 11 embryos. This process was
also used to determine if the changes in ChIP-chip sig-
nal were correlated with changes in chromatin accessi-
bility at the same genomic regions (Figure 7; Additional
file 11). For these plots, the ratio between input DNA
normalized ChIP-chip scores for stage X and scores for
stage Y was plotted against the ratio between DNAse-
seq density for stage X and density for stage Y for the
following six pairwise comparisons: HB 2 stage 5/HB 2
s t a g e9 ;H B2s t a g e9 / H B2s t a g e5 ;M E Ds t a g e5 / M E D
stage 10; MED stage 5/MED stage 14; MED stage 10/
MED stage 5; and MED stage 14/MED stage 5.
Additional material
Additional file 1: Replica DNase-seq data closely agree.
Additional file 2: Summary of 5% FDR accessible regions in
euchromatic DNA for stage 5, 9, 10, 11 and 14 embryos.
Additional file 3: 5% FDR accessible regions in the euchromatic
genome for stage 5, 9, 10, 11 and 14 embryos.
Additional file 4: ChIP-chip input crosslinked DNA is not
appreciably enriched in either highly bound or highly accessible
genomic regions.
Additional file 5: The overlap between 1% FDR ChIP-chip peaks
versus 5% FDR accessible regions.
Additional file 6: Most highly accessible regions are bound by
regulatory factors.
Additional file 7: The level of transcription factor occupancy
correlates with the degree of DNaseI accessibility.
Additional file 8: Comparison of ChIP-chip scores for occurrences of
DNA recognition sequences in accessible versus closed chromatin
regions.
Additional file 9: Levels of MED factor occupancy and DNaseI
accessibility change between developmental stages.
Additional file 10: Change in DNA binding levels in vivo between
developmental stages.
Additional file 11: Temporal changes in levels of MED occupancy
correlate with changes in DNaseI accessibility.
Additional file 12: 1% and 25% FDR ChIP-chip bound regions for
HB at stage 9 and MED at stages 10 and 14.
Additional file 13: Position weight matrices of factors’ intrinsic DNA
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